Dergiler / Clinical and Experimental Health Sciences / 2022 / Cilt: 12 - Sayı: 1

Reprocessing Cost Analysis of Specimens Rejected in Laboratory: Results from the Perspective of the Costs to the Hospital

Sayfa
67–74
Yayın Tarihi
2022-03-30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These are the criticalapproaches that will improve the service quality of laboratories and patient safety.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The objective of the study is to analyze the additional costs of reprocessing the specimens rejected in the laboratory to the hospital.Methods: The data is acquired from the Düzce University Medical Application and Research Hospital (DUMARH) laboratories. 5-year (2015-2019) data was retrospectively reviewed and subjected to document analysis.Results: The rate of the total rejected specimens has increased throughout the years. (2015, 0.88% – 2019, 2.12%).
📊
Temel Bulgular & Veri:The most prominentrejection reasons are hemolysis specimen (32.9%), insufficient specimen (17.25%), clotted specimen (15.4%) and inaccurate examinationrequest (10.64%).
💡
Sonuç & Katkı:These are the criticalapproaches that will improve the service quality of laboratories and patient safety.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2015-2019 Verileri
⚙️Değişkenler:Laboratory · Rejected Specimen · Reprocessing

Abstract

Objective: The objective of the study is to analyze the additional costs of reprocessing the specimens rejected in the laboratory to the hospital.Methods: The data is acquired from the Düzce University Medical Application and Research Hospital (DUMARH) laboratories. 5-year (2015-2019) data was retrospectively reviewed and subjected to document analysis.Results: The rate of the total rejected specimens has increased throughout the years. (2015, 0.88% – 2019, 2.12%). The most prominentrejection reasons are hemolysis specimen (32.9%), insufficient specimen (17.25%), clotted specimen (15.4%) and inaccurate examinationrequest (10.64%). While the reprocessing cost of specimens was 12.085 dollars in 2015, it increased to 51.132 dollars in 2019. It is seen that therejection rate has increased as the specimen number increased and the reprocessing costs have increased since the inflation in Turkey increasedand the purchasing power of the hospital has decreased throughout the years.Conclusion: In order to decrease and prevent the rejected specimen, there is a need for phlebotomy training, especially for nursing and otherhealthcare professionals, and strict quality control and standard operating procedures for the pre-analytical phase. These are the criticalapproaches that will improve the service quality of laboratories and patient safety.

🔖

Bu Makaleye Atıf Yap

BOZDEMİR, E., KURUTKAN, M. N., TERZİ, M. (2022). Reprocessing Cost Analysis of Specimens Rejected in Laboratory: Results from the Perspective of the Costs to the Hospital. Clinical and Experimental Health Sciences, Cilt: 12 - Sayı: 1, 67–74. https://ajindex.com/articles/481363

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü. Klinik Mikrobiyoloji Laboratuvarları Kalite Yönetimi Rehberi. Ankara; 2014 [accessed 2020 Apr 24]. www.pozitifmatbaa.com
  2. Da Rin G. Pre-analytical workstations: A tool for reducing laboratory errors. Clin Chim Acta. 2009;404:68–74.
  3. Guimarães AC, Wolfart M, Brisolara MLL, et al. Causes of rejection of blood samples handled in the clinical laboratory of a University Hospital in Porto Alegre. Clin Biochem. 2012;45:123–126.
  4. Green SF. The cost of poor blood specimen quality and errors in preanalytical processes. Clin Biochem. 2013;46:1175–1179.
  5. Goldschmidt H, Lent R. Gross errors and work flow analysis in the clinical laboratory. Klin Biochem Metab. 1995;3:131–140
  6. Plebani M, Lippi G. To err is human. To misdiagnose might be deadly. Clin. Biochem. 2010. p. 1–3.
  7. ECRI Institute. PSO Monthly Brief From the ECRI Institute PSO Deep Dive: An Examination of “Lab” Errors Check out ECRI Institute. 2014
  8. Sağlık Bakanlığı. Güvenlik Raporlama Sistemi 2016 Yılı İstatistik ve Analiz Raporu. 2018 [accessed 2020 Apr 24]. www.grs.saglik.gov.tr
  9. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing. Clin. Chem. Lab. Med. Walter de Gruyter; 2007. p. 720–727.
  10. Howanitz PJ. Errors in laboratory medicine: Practical lessons to improve patient safety. Arch Pathol Lab Med. 2005;129:1252–1261.
  11. Güvenç Y. Poliklinik, Servis ve Acil Kanlarında Numune Red Analizi: Eğitim ve Yeni Yaklaşımlar. Türk Klin Biyokim Derg. 2017;15:119–128
  12. Shiferaw MB, Yismaw G, Getachew H. Specimen rejections among referred specimens through referral network to the Amhara Public Health Institute for laboratory testing, Bahir Dar, Ethiopia. BMC Res Notes. 2018;11.
  13. Cao L, Chen M, Phipps RA, et al. Causes and impact of specimen rejection in a clinical chemistry laboratory. Clin Chim Acta. 2016;458:154–158.
  14. Erdal EP, Mitra D, Khangulov VS, et al. The economic impact of poor sample quality in clinical chemistry laboratories: results from a global survey. Ann Clin Biochem. 2017;54:230–239. https://doi.